Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.

Drug Metab Rev

a Department of Sciences, IINFACTS - Institute of Research and Advanced Training in Health Sciences and Technologies , University Institute of Health Sciences (IUCS), CESPU, CRL , Gandra , Portugal.

Published: February 2017

AI Article Synopsis

Article Abstract

Psilocybin and psilocin are controlled substances in many countries. These are the two main hallucinogenic compounds of the "magic mushrooms" and both act as agonists or partial agonists at 5-hydroxytryptamine (5-HT) subtype receptors. During the last few years, psilocybin and psilocin have gained therapeutic relevance but considerable physiological variability between individuals that can influence dose-response and toxicological profile has been reported. This review aims to discuss metabolism of psilocybin and psilocin, by presenting all major and minor psychoactive metabolites. Psilocybin is primarily a pro-drug that is dephosphorylated by alkaline phosphatase to active metabolite psilocin. This last is then further metabolized, psilocin-O-glucuronide being the main urinary metabolite with clinical and forensic relevance in diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03602532.2016.1278228DOI Listing

Publication Analysis

Top Keywords

psilocybin psilocin
16
metabolism psilocybin
8
clinical forensic
8
psilocin
5
psilocin clinical
4
forensic toxicological
4
toxicological relevance
4
psilocybin
4
relevance psilocybin
4
psilocin controlled
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!